The majority of drugs that enter Phase III end up getting approved by the FDA. While final approval might still be some time away, the near-certainty of approval warrants manufacturers at Phase III to begin completing the legwork needed to bring a drug to the market. On top of additional Market Access and Market Intelligence initiatives, you also need to begin the long list of Commercialization activities that need completed.
That includes beginning to develop your channel strategy, starting the state licensing process, getting your drug listed in compendia databases, and much more.
Services We Recommend
at Phase III
Managing the logistics and flow of information about your new retail product is a key to being as efficient as possible with your commercialization efforts.
Bringing specialty drugs to market, while increasingly common, requires properly managing your channel and the flow of data and analytics.
Ensuring that patients, healthcare providers and caregivers all have the information they need to access and properly use your treatment is important for all new drug launches.
Many see compendia databases as just a pricebook, but they’re so much more. In fact, an incorrect classification can mean a failed launch.
In many ways, timely state licensing is just as important for your launch as the FDA approval process.
Missing or incorrect serialization decisions can put your launch on hold, or cause considerable increases in costs
To maximize your revenue, it’s vital that you develop proper strategy that takes payers, physicians and patients into consideration.
Gaining a thorough understanding of the market, as well as the future environment, is critical for sound decision making.
It’s imperative manufacturers have a thorough understanding of out of pocket (OOP) costs and the reimbursement support options available to them.
To understand the pricing and market access potential for new treatments, clients need to hear from KOLs and payers. At Two Labs, we conduct blinded and unblinded panels, depending on your needs.
In today’s competitive landscape, a one-size-fits-all approach to your market access strategy is not enough.
Increase your awareness of your drug’s disease landscape and competitor activities to determine how to differentiate your drug in the market to be successful.
Save time and money without losing out on important developments in the pharma world with our full medical congress coverage services.
Understand what physicians and patients want to see from your new product with our in-depth primary source interviewing services.
Gain the most from your benchmarking study with our key insights, complete with an action list and detailed recommendations.
We help optimize your launch strategy by analyzing what worked and didn’t work for similar drugs so you can properly develop a successful launch strategy.
Our Competitive Simulations are your key to deeper competitor insight and a smarter business development strategy.
Our extensive experience monitoring and assessing all therapeutic categories allows us to provide insights to support licensing and acquisition decisions.